Stock ILMN ILLUMINA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Illumina, Inc.

Equities

ILMN

US4523271090

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-15 pm EDT 		5-day change 1st Jan Change
121.2 USD -4.65% Intraday chart for Illumina, Inc. -6.89% -12.98%
Apr. 12 Leerink Partners Adjusts Illumina's Price Target to $155 From $170 MT
Apr. 12 Illumina Secures European Commission's Approval for Grail Divestment MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Illumina's planned divestment of GRAIL approved by the European Commission
PR
Leerink Partners Adjusts Illumina's Price Target to $155 From $170
MT
Illumina Secures European Commission's Approval for Grail Divestment
MT
European Commission Clears Illumina's Proposed Sale of Cancer Test Maker Grail
MT
EU approves Illumina's plan to divest cancer test maker Grail
RE
Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeed
RE
Illumina Names Ankur Dhingra as Chief Financial Officer
MT
Illumina CFO Goswami to depart, Summit Therapeutics' Dhingra named successor
RE
Illumina appoints Ankur Dhingra Chief Financial Officer, Jakob Wedel Chief Strategy and Corporate Development Officer
PR
Illumina, Inc. Announces Chief Financial Officer Changes
CI
Illumina, Inc. Announces Executive Changes
CI
RBC Cuts Price Target on Illumina to $253 From $258, Keeps Outperform Rating
MT
Illumina to Announce First Quarter 2024 Financial Results on Thursday, May 2, 2024
PR
GRAIL Presents New Data on Galleri and Its Methylation Platform at the Annual American Association for Cancer Research Meeting
AQ
US Equity Markets Close Higher Thursday, Extending Gains From Wednesday
MT
Illumina Shares Up After EU Court Adviser Says Antitrust Regulators Overstepped in Halting Grail Merger
MT
Boost for Illumina as court adviser rejects EU merger powers
RE
EU court should back Illumina's appeal against EU review of Grail deal, court adviser says
RE
OTR Global Downgrades Illumina to Mixed From Positive
MT
Illumina Investor Carl Icahn Withdraws Bid for Board Seat, Continues Legal Battle Over Grail Acquisition
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ILMN Stock
  4. News Illumina, Inc.